trending Market Intelligence /marketintelligence/en/news-insights/trending/_-fQqDo61-Jl8yNPKCQJzQ2 content esgSubNav
In This List

Valeant closes $750M debt offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Valeant closes $750M debt offering

Valeant Pharmaceuticals International Inc. closed an offering of $750 million of 5.50% senior secured notes due 2025.

Net proceeds were used, along with cash on hand, to prepay a portion of company's outstanding series F tranche B term loan facilities due 2022 and to pay related fees and expenses.

After the closing, Valeant successfully completed the repricing of its series F tranche B term loan. The amendment reduces the annual interest rate on the facilities by 1.25% and makes certain other changes.